Literature DB >> 3139740

Spontaneous growth hormone and somatomedin-C/insulin-like growth factor-I secretion in obese subjects during puberty.

F Minuto1, A Barreca, P Del Monte, P Fortini, M Resentini, F Morabito, G Giordano.   

Abstract

It has been reported that adult obese subjects present a reduced growth hormone secretion. As no data are available in the pubertal period, which is characterized in lean subjects by an increased spontaneous growth hormone secretion, the growth hormone circadian concentration was studied in a group of 18 obese male subjects in different pubertal stages, and compared to 26 age-matched control subjects. The data observed evidenced no statistically relevant differences regarding LH and FSH circadian secretion and morning testosterone concentration. On the contrary a statistically significant (p less than 0.02) difference in growth hormone 24 h integrated concentration was evident, particularly in prepubertal subjects; the sleep-related peak was evident in 28% of obese subjects and in 85% of controls. Sm-C/IGF-I concentration was similar to the concentration observed in controls in the prepubertal stage, but did not show the expected increase in the late puberty. Auxological data, performed on a sample of 80 subjects, showed both advanced height and bone age at beginning of puberty, and a trend toward a reduction of percentile for height in parallel with the pubertal maturation, suggesting that pubertal growth spurt in obese subjects is at least less pronounced than in lean subjects. It is concluded that GH and Sm-C/IGF-I secretion is impaired during puberty in obese subjects, leading to a reduced growth rate, while in the prepubertal period factors other than GH may replace or even potentiate its action.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139740     DOI: 10.1007/bf03350166

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  Responsiveness of pituitary hGH to GRH1-44 in juveniles with obesity.

Authors:  A Pertzelan; R Keret; B Bauman; Z Josefsberg; Z Ben-Zeev; B Szoke; A M Comaru-Schally; A V Schally; Z Laron
Journal:  Acta Endocrinol (Copenh)       Date:  1986-02

2.  Nocturnal growth hormone secretion: correlation with sleeping EEG in adults and pattern in children and adolescents with non-pituitary dwarfism, overgrowth and with obesity.

Authors:  H J Quabbe; H Helge; S Kubicki
Journal:  Acta Endocrinol (Copenh)       Date:  1971

3.  Somatomedins in adolescence: a cross-sectional study of the effect of puberty on plasma insulin-like growth factor I and II levels.

Authors:  A M Luna; D M Wilson; C J Wibbelsman; R C Brown; R J Nagashima; R L Hintz; R G Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

Review 4.  Endocrine function in human obesity.

Authors:  A R Glass; K D Burman; W T Dahms; T M Boehm
Journal:  Metabolism       Date:  1981-01       Impact factor: 8.694

5.  Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity.

Authors:  P G Kopelman; K Noonan; R Goulton; A J Forrest
Journal:  Clin Endocrinol (Oxf)       Date:  1985-07       Impact factor: 3.478

6.  Growth without growth hormone: evidence for a potent circulating human growth factor.

Authors:  M E Geffner; B M Lippe; N Bersch; A Van Herle; S A Kaplan; M J Elders; D W Golde
Journal:  Lancet       Date:  1986-02-15       Impact factor: 79.321

7.  Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction.

Authors:  T Williams; M Berelowitz; S N Joffe; M O Thorner; J Rivier; W Vale; L A Frohman
Journal:  N Engl J Med       Date:  1984-11-29       Impact factor: 91.245

8.  Prolactin and somatomedin studies in the syndrome of growth hormone-independent growth.

Authors:  P D Gluckman; I M Holdaway
Journal:  Clin Endocrinol (Oxf)       Date:  1976-09       Impact factor: 3.478

9.  Insulin-like growth factors in the fed and fasted states.

Authors:  T J Merimee; J Zapf; E R Froesch
Journal:  J Clin Endocrinol Metab       Date:  1982-11       Impact factor: 5.958

10.  Effect of l-dopa on growth hormone, glucose, insulin, and cortisol response in obese subjects.

Authors:  B Vizner; Z Reiner; M Sekso
Journal:  Exp Clin Endocrinol       Date:  1983-01
View more
  9 in total

Review 1.  Minor head injury.

Authors:  T F Beattie
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

2.  Reduced levels of growth hormone, insulin-like growth factor-I and binding protein-3 in patients with shunted hydrocephalus.

Authors:  T Löppönen; A L Saukkonen; W Serlo; P Tapanainen; A Ruokonen; M Knip
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

3.  Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test.

Authors:  M Maccario; C Gauna; M Procopio; L Di Vito; R Rossetto; S E Oleandri; S Grottoli; C Ganzaroli; G Aimaretti; E Ghigo
Journal:  J Endocrinol Invest       Date:  1999-06       Impact factor: 4.256

4.  Patterns of linear growth and skeletal maturation from birth to 18 years of age in overweight young adults.

Authors:  W Johnson; S D Stovitz; A C Choh; S A Czerwinski; B Towne; E W Demerath
Journal:  Int J Obes (Lond)       Date:  2011-11-29       Impact factor: 5.095

Review 5.  Growth Hormone and Counterregulation in the Pathogenesis of Diabetes.

Authors:  Xuehong Dong; Lei Su; Mary-Elizabeth Patti
Journal:  Curr Diab Rep       Date:  2022-08-24       Impact factor: 5.430

6.  Pediatric Idiopathic Intracranial Hypertension: Age, Gender, and Anthropometric Features at Diagnosis in a Large, Retrospective, Multisite Cohort.

Authors:  Claire A Sheldon; Grace L Paley; Rui Xiao; Anat Kesler; Ori Eyal; Melissa W Ko; Chantal J Boisvert; Robert A Avery; Vincenzo Salpietro; Paul H Phillips; Gena Heidary; Shana E McCormack; Grant T Liu
Journal:  Ophthalmology       Date:  2016-09-28       Impact factor: 12.079

7.  IGF-1 Levels are Inversely Associated With Metabolic Syndrome in Obstructive Sleep Apnea.

Authors:  Suelem Izumi; Fernando F Ribeiro-Filho; Gláucia Carneiro; Sônia M Togeiro; Sérgio Tufik; Maria T Zanella
Journal:  J Clin Sleep Med       Date:  2016-04-15       Impact factor: 4.062

8.  Growth hormone binding protein activity in obese children.

Authors:  S Seminara; A Filpo; F La Cauza; A Faedda; A Miola; S Pellizzone; M Casati; S Loche
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

9.  Low level of IGF-1 in obesity may be related to obstructive sleep apnea syndrome.

Authors:  Ahmet Ursavas; Mehmet Karadag; Yesim Ozarda Ilcol; Ilker Ercan; Basak Burgazlioglu; Funda Coskun; R Oktay Gozu
Journal:  Lung       Date:  2007-08-27       Impact factor: 3.777

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.